Markers of Tissue Injury and Rhabdomyolysis in Patients With Major Trauma

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-06-15

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Major trauma is associated with a release of alarmins (DAMPs - damage-associated molecular patterns) from the injured tissues. This process results in the activation of the immune system, which is one of the main mechanisms participating in the development of organ dysfunctions in patients with major trauma.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Inflammation and Infection in Trauma, Role in Posttraumatic Complications

NCT00192907

Trauma

UNKNOWN

Polytrauma and Resuscitation Impact on Innate Immunity

NCT06314841

Wounds and Injuries

TERMINATED

Inflammatory Response After Muscle and Skeleton Trauma

NCT00710411

Multiple Trauma

COMPLETED

The Usefulness of Inflammatory Markers to Predict Poor Outcomes for Trauma Patients

NCT05441787

Trauma Injury Trauma, Multiple

COMPLETED

Immune-cell Membrane Trafficking

NCT00638521

Severe Trauma

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Major trauma is associated with a release of alarmins (DAMPs - damage-associated molecular patterns) from the injured tissues. This process results in the activation of the immune system, which is one of the main mechanisms participating in the development of organ dysfunctions in patients with major trauma. Limited literary sources describe a correlation between the mitochondrial DNA (mDNA) and the value of plasma creatine kinase (sCK) (which is released from the injured muscles), which suggests a possible correlation between the number of released alarmins and the degree of rhabdomyolysis (damage of striated muscles). Rhabdomyolysis is further - due to the direct nephrotoxicity of myoglobin (sMb) released from the injured muscles - a significant factor participating in the development of acute renal failure in patients with serious injuries. Considering the fact that the serious injury need not include a vast damage of the muscle mass (especially in traumas with a minimal impairment of extremities), the correlation between the DAMPs and sCK/sMb values need not be constant in relation to the extent and localization of the injury defined with the AIS (Abbreviated Injury Scale) and ISS (Injury Severity Scale) scales. The DAMPs released from injured tissues immediately after trauma include HMGB-1 (high mobility group box 1); a correlation has been observed between the early post-injury levels of HMGB-1 and unfavorable outcome (defined with development of organ dysfunctions and increased mortality). Considering the fact that the DAMPs examination (including HMGB-1) are routinely available, and are also rather expensive, they are not a standard part of examinations performed in patients with serious trauma. Determination of correlation between HMGB-1 and the routinely available examinations of sCK and sMb would make the use of sCK and sMb examinations as direct indicators of mechanical tissue damage. Furthermore, this data has a significant descriptive impact in case of direct inclusion of sCK and sMb into predictive scoring systems, which currently do not contain relevant physiological parameters correlating with the extent of the injury.

In the second part of the study, the authors will concentrate upon evaluation of correlation of HMGB-1, serum creatine kinase and serum myoglobin in relation to the development of acute kidney injury (AKI), and in relation to the values of AKI markers, specifically NGAL (neutrophil-gelatinase associated lipocalin). The currently used AKI criteria are based upon relatively imprecise and late parameters (urine output, level of serum creatinine), and that is why AKI is identified in the clinical practice only in the stage of advanced and irreversible morphological and functional changes of kidneys.

The aims of the study are the following:

* To verify the correlation between the levels of circulating alarmins (HMGB-1) and the levels of sCK and sMb
* To identify the correlation between the levels of circulating alarmins and localization of the injury (according to AIS and ISS scoring systems)
* Mutual comparison of predictive levels of sCK and sMb in relation to the development of post-injury kidney failure
* Mutual comparison of predictive levels of sCK and sMb in relation to the serum and urine levels of AKI biomarkers
* Comparison of predictive levels of serum and urine NGAL in relation to the development of post-injury AKI

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tissue Injury Major Trauma Rhabdomyolysis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with major trauma

Patients with major trauma will be included in the study.

Laboratory analysis - upon admission

Intervention Type DIAGNOSTIC_TEST

Laboratory analysis will be performed upon admission of the patient to the hospital. Levels of the following parameters will be determined: HMGB-1, sCK, sMb, serum NGAL, and urine NGAL

Laboratory analysis - 24 hours after injury

Intervention Type DIAGNOSTIC_TEST

Laboratory analysis will be performed upon admission of the patient to the hospital. Levels of the following parameters will be determined: sCK, sMb, serum NGAL, and urine NGAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Laboratory analysis - upon admission

Laboratory analysis will be performed upon admission of the patient to the hospital. Levels of the following parameters will be determined: HMGB-1, sCK, sMb, serum NGAL, and urine NGAL

Intervention Type DIAGNOSTIC_TEST

Laboratory analysis - 24 hours after injury

Laboratory analysis will be performed upon admission of the patient to the hospital. Levels of the following parameters will be determined: sCK, sMb, serum NGAL, and urine NGAL

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* diagnosis of polytrauma
* ISS ≥ 16

Exclusion Criteria

* history of a significant kidney impairment
* pregnancy
* injuries incompatible with life, with anticipated survival \< 24 hours
* transfer to palliative care within the first 24 hours after injury
* death within the first 24 hours after injury

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No